MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.neurobiolaging.2021.01.008

Медицинская библиотека · Neurobiology of aging · 2021

KL∗VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗4 carriers.

Belloy Michael E, Eger Sarah J, Le Guen Yann, Napolioni Valerio, Deters Kacie D, Yang Hyun-Sik, Scelsi Marzia A, Porter Tenielle, James Sarah-Naomi, Wong Andrew, Schott Jonathan M, Sperling Reisa A, Laws Simon M, Mormino Elisabeth C, He Zihuai, Han Summer S, Altmann Andre, Greicius Michael D, A4 Study Team, Insight 46 Study Team, Australian Imaging Biomarkers and Lifestyle (AIBL) Study, Alzheimer's Disease Neuroimaging Initiative

СтатьяМетаанализПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПоддержка правительства СШАПеревод пока не подготовлен

Аннотация

KLOTHO∗VS heterozygosity (KL∗VSHET+) was recently shown to be associated with reduced risk of Alzheimer's disease (AD) in APOE∗4 carriers. Additional studies suggest that KL∗VSHET+ protects against amyloid burden in cognitively normal older subjects, but sample sizes were too small to draw definitive conclusions. We performed a well-powered meta-analysis across 5 independent studies, comprising 3581 pre-clinical participants ages 60-80, to investigate whether KL∗VSHET+ reduces the risk of having an amyloid-positive positron emission tomography scan. Analyses were stratified by APOE∗4 status. KL∗VSHET+ reduced the risk of amyloid positivity in APOE∗4 carriers (odds ratio = 0.67 [0.52-0.88]; p = 3.5 × 10-3), but not in APOE∗4 non-carriers (odds ratio = 0.94 [0.73-1.21]; p = 0.63). The combination of APOE∗4 and KL∗VS genotypes should help enrich AD clinical trials for pre-symptomatic subjects at increased risk of developing amyloid aggregation and AD. KL-related pathways may help elucidate protective mechanisms against amyloid accumulation and merit exploration for novel AD drug targets. Future investigation of the biological mechanisms by which KL interacts with APOE∗4 and AD are warranted.

Для цитирования: Belloy Michael E, Eger Sarah J, Le Guen Yann, Napolioni Valerio, Deters Kacie D, Yang Hyun-Sik, Scelsi Marzia A, Porter Tenielle, James Sarah-Naomi, Wong Andrew, Schott Jonathan M, Sperling Reisa A, Laws Simon M, Mormino Elisabeth C, He Zihuai, Han Summer S, Altmann Andre, Greicius Michael D, A4 Study Team, Insight 46 Study Team, Australian Imaging Biomarkers and Lifestyle (AIBL) Study, Alzheimer's Disease Neuroimaging Initiative. KL∗VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗4 carriers.. Neurobiology of aging. 2021. DOI: 10.1016/j.neurobiolaging.2021.01.008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.